SEC Form 4 · accession 0000899243-17-016222
PROTHENA CORP PUBLIC LTD CO · PRTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wagner M. Zago
Officer — Chief Scientific Officer
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559053
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $51.32 | Jun 9, 2017 | A | 20,000 | A | — | Jun 9, 2027 | Ordinary Shares | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 9, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.